Survival in Children with Perinatally Acquired Human Immunodeficiency Virus Type 1 Infection

New England Journal of Medicine

Volumn 321, Issue 26, 1989, Pages 1791-1796

  Scott, Gwendolyn B ^a   Hutto, Cecelia ^a   Makuch, Robert W ^b   Mastrucci, Mary T ^a   O'connor, Theresa ^b   Mitchell, Charles D ^a   Trapido, Edward J ^a   Parks, Wade P ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERINATAL INFECTION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; VERTICAL TRANSMISSION;

EID: 0024806428     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198912283212604     Document Type: Article

References (30)

1. Oleske J, Minnefor A, Cooper R Jr, et al. Immune deficiency syndrome in children. JAMA 1983; 249: 2345–9.
2. Rubinstein A, Sicklick M, Gupta A, et al. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA 1983; 249: 2350–6.
3. Scott GB, Buck BE, Leterman JG, Bloom FL, Parks WP. Acquired immunodeficiency syndrome in infants. N Engl J Med 1984; 310: 76–81.
4. Pahwa S, Kaplan M, Fikrig S, et al. Spectrum of human T-cell lymphotrophic virus type III infection in children: recognition of symptomatic, asymptomatic, and seronegative patients. JAMA 1985; 255: 2299–305.
5. Parks W, Scott G. An overview of pediatric AIDS: approaches to diagnosis and outcome assessment. In: Broder S, ed. AIDS: modern concepts and therapeutic challenges. New York: Marcel Dekker, 1987:245–62.
6. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1987; 36: 225–36.
7. Cowan MJ, Hellmann D, Chudwin D, Wara DW, Chang RS, Ammann AJ. Maternal transmission of acquired immune deficiency syndrome. Pediatrics 1984; 73: 382–6.
8. Scott GB, Fischl MA, Klimas N, et al. Mothers of infants with the acquired immunodeficiency syndrome: evidence for both symptomatic and asymptomatic carriers. JAMA 1985; 253: 363–6.
9. Rogers MF. AIDS in children: a review of the clinical, epidemiologic and public health aspects. Pediatr Infect Dis 1985; 4: 230–6.
10. Rogers MF, Thomas PA, Starcher ET, Noa MC, Bush TJ, Jaffe HW. Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control National Surveillance, 1982 to 1985. Pediatrics 1987; 79: 1008–14.
11. Lampert R, Milberg J, O'Donnell R, Kristal A, Thomas P. Life table analysis of children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1986; 5: 374–5.
12. Krasinski K, Borkowsky W, Holzman RS. Prognosis of human immunodeficiency virus infection in children and adolescents. Pediatr Infect Dis J 1989; 8: 216–20.
13. Parks WP, Parks ES, Fischl MA, et al. HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trial. J Acquir Immune Defic Syndr 1988; 1: 125–30.
14. Kanner SB, Parks ES, Scott GB, Parks WP. Simultaneous infections with human T cell leukemia virus type I and the human immunodeficiency virus. J Infect Dis 1987; 155: 617–25.
15. Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames: Iowa State University Press, 1967.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
17. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc (A) 1972; 135: 185–98.
18. Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics 1982; 38: 29–41.
19. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.
20. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187–220.
21. Hoff R, Berardi VP, Weiblen BJ, Mahoney-Trout L, Mitchell ML, Grady GF. Seroprevalence of human immunodeficiency virus among childbearing women: estimation by testing samples of blood from newborns. N Engl J Med 1988; 318: 525–30.
22. Landesman S, Minkoff H, Holman S, McCalla S, Sijn O. Serosurvey of human immunodeficiency virus infection in parturients: implications for human immunodeficiency virus testing programs of pregnant women. JAMA 1987; 258: 2701–3.
23. Mok JQ, Giaquinto C, De Rossi A, et al. Infants born to mothers seropositive for human immunodeficiency virus: preliminary findings from a multi-centre European study. Lancet 1987; 1: 1164–8.
24. Blanche S, Rouzioux C, Moscato M-LG, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989; 320: 1643–8.
25. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989; 320: 1637–42.
26. Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome: experience with 5833 cases in New York City. N Engl J Med 1987; 317: 1297–302.
27. Byar DP. Identification of prognostic factors. In: Buyse ME, Staquet MJ, Sylvester RJ, eds. Cancer therapy: prognostic factors and criteria of response. New York: Raven Press, 1975:423–43.
28. Feinstein AR. Clinical biostatistics. XV. The process of prognostic stratification. Clin Pharmacol Ther 1972; 13: 442–57, 609–24.
29. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR 1985; 34: 721–32.
30. American Academy of Pediatrics, Task Force on Pediatric AIDS. Perinatal human immunodeficiency virus infection. Pediatrics 1988; 82: 941–4.